Knudsen Jenny Dahl, Odenholt Inga, Erlendsdottir Helga, Gottfredsson Magnus, Cars Otto, Frimodt-Møller Niels, Espersen Frank, Kristinsson Karl G, Gudmundsson Sigurdur
Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark.
Antimicrob Agents Chemother. 2003 Aug;47(8):2499-506. doi: 10.1128/AAC.47.8.2499-2506.2003.
Pharmacokinetic (PK) and pharmacodynamic (PD) properties for the selection of resistant pneumococci were studied by using three strains of the same serotype (6B) for mixed-culture infection in time-kill experiments in vitro and in three different animal models, the mouse peritonitis, the mouse thigh, and the rabbit tissue cage models. Treatment regimens with penicillin were designed to give a wide range of T(>MIC)s, the amounts of time for which the drug concentrations in serum were above the MIC. The mixed culture of the three pneumococcal strains, 10(7) CFU of strain A (MIC of penicillin, 0.016 micro g/ml; erythromycin resistant)/ml, 10(6) CFU of strain B (MIC of penicillin, 0.25 micro g/ml)/ml, and 10(5) CFU of strain C (MIC of penicillin, 4 micro g/ml)/ml, was used in the two mouse models, and a mixture of 10(5) CFU of strain A/ml, 10(4) CFU of strain B/ml, and 10(3) CFU of strain C/ml was used in the rabbit tissue cage model. During the different treatment regimens, the differences in numbers of CFU between treated and control animals were calculated to measure the efficacies of the regimens. Selective media with erythromycin or different penicillin concentrations were used to quantify the strains separately. The efficacies of penicillin in vitro were similar when individual strains or mixed cultures were studied. The eradication of the bacteria, independent of the susceptibility of the strain or strains or the presence of the strains in a mixture or on their own, followed the well-known PK and PD rules for treatment with beta-lactams: a maximum efficacy was seen when the T(>MIC) was >40 to 50% of the observation time and the ratio of the maximum concentration of the drug in serum to the MIC was >10. It was possible in all three models to select for the less-susceptible strains by using insufficient treatments. In the rabbit tissue cage model, a regrowth of pneumococci was observed; in the mouse thigh model, the ratio between the different strains changed in favor of the less-susceptible strains; and in the mouse peritonitis model, the susceptible strain disappeared and was overgrown by the less-susceptible strains. These findings with the experimental infection models confirm the importance of eradicating all the bacteria taking part in the infectious process in order to avoid selection of resistant clones.
通过使用三株相同血清型(6B)的菌株进行体外时间杀灭实验以及在三种不同动物模型(小鼠腹膜炎、小鼠大腿和兔组织笼模型)中建立混合培养感染,研究了用于选择耐药肺炎球菌的药代动力学(PK)和药效学(PD)特性。设计了青霉素治疗方案以提供广泛的T(> MIC)值,即血清中药物浓度高于MIC的时间量。在两种小鼠模型中使用了三种肺炎球菌菌株的混合培养物,即每毫升含10⁷CFU的A菌株(青霉素MIC为0.016μg/ml;对红霉素耐药)、每毫升含10⁶CFU的B菌株(青霉素MIC为0.25μg/ml)和每毫升含10⁵CFU的C菌株(青霉素MIC为4μg/ml),在兔组织笼模型中使用了每毫升含10⁵CFU的A菌株、每毫升含10⁴CFU的B菌株和每毫升含10³CFU的C菌株的混合物。在不同治疗方案期间,计算治疗组和对照组动物之间CFU数量的差异以衡量方案的疗效。使用含红霉素或不同青霉素浓度的选择性培养基分别对菌株进行定量。研究单个菌株或混合培养物时,青霉素在体外的疗效相似。细菌的根除,无论菌株的敏感性如何,也无论菌株是混合存在还是单独存在,均遵循众所周知的β-内酰胺类药物治疗的PK和PD规则:当T(> MIC)大于观察时间的40%至50%且血清中药物的最大浓度与MIC的比值大于10时,疗效最佳。在所有三种模型中,通过使用不足的治疗方法都有可能选择出较不敏感的菌株。在兔组织笼模型中,观察到肺炎球菌重新生长;在小鼠大腿模型中,不同菌株之间的比例发生变化,有利于较不敏感的菌株;在小鼠腹膜炎模型中,敏感菌株消失,被较不敏感的菌株过度生长。这些实验感染模型的研究结果证实了根除参与感染过程的所有细菌以避免选择耐药克隆的重要性。